Endophenotypes and Biological Markers of Schizophrenia: From Biological Signs of Illness to Novel Treatment Targets

E-ISSN： 1873-4286|19|36|6462-6479

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.36, 2013-11, pp. : 6462-6479

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Targets for Drugs in Schizophrenia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite

Anthraquinones: Analytical Techniques as a Novel Tool to Investigate on the Triggering of Biological Targets

Current Drug Targets, Vol. 12, Iss. 3, 2011-01 ,pp. : 366-380

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Novel Techniques as a Tool to Investigate on the Triggering of Biological Targets)

Current Drug Targets, Vol. 14, Iss. 9, 2013-08 ,pp. : 937-937

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Markers for Multiple Sclerosis

Current Medicinal Chemistry, Vol. 14, Iss. 18, 2007-08 ,pp. : 1956-1965

Bentham Science Publishers

Access to resources Recommend Favorite

Biological Markers of Age-Related Memory Deficits: Treatment of Senescent Physiology

By Foster Thomas C.

CNS Drugs, Vol. 20, Iss. 2, 2006-01 ,pp. : 153-166

Adis International

Access to resources Recommend Favorite